Riyaz Bashir (@riyazbashir) 's Twitter Profile
Riyaz Bashir

@riyazbashir

ID: 2889976085

calendar_today24-11-2014 00:16:05

243 Tweet

528 Followers

269 Following

Cardiology Today (@cardiologytoday) 's Twitter Profile Photo

For patients with chronic thromboembolic pulmonary hypertension, balloon pulmonary angioplasty was associated with an improvement in pulmonary hemodynamic parameters and quality of life measures Temple Health @Riyazbashir Healio Pulmonology #cardiotwitter healio.com/news/cardiac-v…

American College of Cardiology (@accintouch) 's Twitter Profile Photo

Q: What is the safety & efficacy of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension? A: Balloon pulmonary angioplasty is safe & effective in patients with chronic thromboembolic pulmonary hypertension. bit.ly/41BU97j #JACCAdvances

Q: What is the safety & efficacy of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension?

A: Balloon pulmonary angioplasty is safe & effective in patients with chronic thromboembolic pulmonary hypertension.

bit.ly/41BU97j #JACCAdvances
CRT Meeting (@crt_meeting) 's Twitter Profile Photo

Join us at 7:30 AM ET Wednesday for cath conference. Riyaz Bashir will discuss refined balloon pulmonary angioplasty in CTEPH; Mauricio G. Cohen, MD, will discuss coronary and peripheral intervention malpractice lawsuits. Email [email protected] for registration link.

Join us at 7:30 AM ET Wednesday for cath conference. <a href="/RiyazBashir/">Riyaz Bashir</a> will discuss refined balloon pulmonary angioplasty in CTEPH; Mauricio G. Cohen, MD, will discuss coronary and peripheral intervention malpractice lawsuits. Email mwhc.cathconference@gmail.com for registration link.
Temple Health News (@templemednews) 's Twitter Profile Photo

The Bashir Endovascular Catheter, invented Temple Med School and developed Thrombolex™, has been approved by the U.S. FDA for treatment of acute pulmonary embolism. Dr. Riyaz Bashir, of Temple Health, is a co-inventor. Read more about the news here: templehealth.org/about/news/end…

Robert A Lookstein MD, MHCDL (@roblookstein) 's Twitter Profile Photo

New publication from the RESCUE trial for #PE Effect of Pharmacomechanical Catheter-Directed Thrombolysis on Segment... sciencedirect.com/science/articl…

Robert A Lookstein MD, MHCDL (@roblookstein) 's Twitter Profile Photo

Another meta-analysis? The PERT Consortium® Catheter-directed thrombolysis compared with systemic thrombolysis and anticoagulation in patients with intermediate- or high-risk pulmonary embolism: systematic review and network meta-analysis cmaj.ca/content/195/24…

Yevgeniy Brailovsky DO MSc FACC (@yevgeniybr) 's Twitter Profile Photo

Please see our accompanying editorial where we highlight important innovations in catheter-based therapies of PE and suggest future directions for outcome measures in interventional PE trials sciencedirect.com/science/articl… Waqas Ullah PERT Consortium

Please see our accompanying editorial where we highlight important innovations in catheter-based therapies of PE and suggest future directions for outcome measures in interventional PE trials sciencedirect.com/science/articl… <a href="/vakasullah/">Waqas Ullah</a> <a href="/PERTConsortium/">PERT Consortium</a>
Thrombolex™ (@thrombolextm) 's Twitter Profile Photo

Attending VEINS 2023? Join us for an informative industry-sponsored break session 10/29 discussing the future of PM-CDT treatment for PE and Venous Disease, featuring Dr. Eric Secemsky. Register for VEINS 2023: viva-foundation.org/register Thrombolex.com #Thrombolex

Attending VEINS 2023? Join us for an informative industry-sponsored break session 10/29 discussing the future of PM-CDT treatment for PE and Venous Disease, featuring Dr. Eric Secemsky. Register for VEINS 2023: viva-foundation.org/register
Thrombolex.com #Thrombolex
TODAY (@todayshow) 's Twitter Profile Photo

20 years ago, NBC journalist David Bloom passed away from a pulmonary embolism while embedded with American troops in Iraq. His widow Melanie joins TODAY to talk about her 20-year mission to raise awareness about blood clots. She is joined by Geoff Barnes to discuss risk factors.

Thrombolex™ (@thrombolextm) 's Twitter Profile Photo

Join Thrombolex today @ VEINS 2023 and discover how the BASHIR™ Family of Endovascular Catheters safely and effectively treats A+VTE. Learn more at Thrombolex.com. #VEINSConference #Thrombolex

Join Thrombolex today @ VEINS 2023 and discover how the BASHIR™ Family of Endovascular Catheters safely and effectively treats A+VTE. Learn more at Thrombolex.com. 

#VEINSConference #Thrombolex
Kashif Chaudhry (@kashifmd) 's Twitter Profile Photo

To anyone who wrongly conflates Israel’s occupation with the Jewish people, know that hundreds of thousands of Israeli Jews oppose the occupation of Palestine & call for peaceful coexistence. There is no excuse for antisemitism in any shape or form. ✡️❤️☪️

Akhilesh Sista (@akhileshsistamd) 's Twitter Profile Photo

2 landmark VTE trials ECLIPSED major milestones on this auspicious day! Congrats Abdul Moiz Hafiz and the SIU team for enrolling PE-TRACT participant number 100, on the same day that C-TRACT enrolled number 200. The PERT Consortium® Society of Interventional Radiology Weill Cornell Medicine Radiology VascularMedicine @NATFthrombosis

Amy Goldberg (@ajgtemplesurg) 's Twitter Profile Photo

Riyaz Bashir and his team continue to make incredible strides with their research. This latest development could lead to major advancements in treating acute pulmonary embolism. Proud of their innovation and dedication to making a real difference in the lives of patients.